SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-277418
Filing Date
2023-11-15
Accepted
2023-11-15 06:04:58
Documents
14
Period of Report
2023-11-14
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d850613d8k.htm   iXBRL 8-K 24508
2 EX-99.1 d850613dex991.htm EX-99.1 6584
6 GRAPHIC g850613dsp5a.jpg GRAPHIC 18245
  Complete submission text file 0001193125-23-277418.txt   176708

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA gh-20231114.xsd EX-101.SCH 2512
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE gh-20231114_lab.xml EX-101.LAB 17204
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gh-20231114_pre.xml EX-101.PRE 10792
8 EXTRACTED XBRL INSTANCE DOCUMENT d850613d8k_htm.xml XML 3393
Mailing Address 3100 HANOVER STREET PALO ALTO CA 94304
Business Address 3100 HANOVER STREET PALO ALTO CA 94304 855-698-8887
Guardant Health, Inc. (Filer) CIK: 0001576280 (see all company filings)

IRS No.: 454139254 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38683 | Film No.: 231408953
SIC: 8071 Services-Medical Laboratories